EEF2K and cancer: For example, a recent assessment of eEF-2K by siRNA-mediated knockdown as well as by a moderately potent ATP-competitive inhibitor of eEF-2K suggested that the contribution of eEF-2K to the proliferation of several common cancer cell lines is minimal [13].